| Company Name | Announcement |
|---|---|
|
Marksans Pharma Limited
Marksans Pharma Limited [03-Jun-2026] |
Marksans Pharma Limited has informed the Exchange about Transcript of Investors/Analyst meet on Q4 FY 26 Audited Financial Results |
|
Max India Limited
Max India Limited [03-Jun-2026] |
Max India Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "Antara Senior Care Forays into Integrative Medicine, Launches One-of-a-kind Clinic for Treatment of Chronic Conditions". |
|
MEP Infrastructure Developers Limit
MEP Infrastructure Developers Limit [03-Jun-2026] |
MEP Infrastructure Developers Limited has informed the Exchange about Corporate Insolvency Resolution Process |
|
Mishra Dhatu Nigam Limited
Mishra Dhatu Nigam Limited [03-Jun-2026] |
Mishra Dhatu Nigam Limited has informed the Exchange about Link of Recording |
|
One Mobikwik Systems Limited
One Mobikwik Systems Limited [03-Jun-2026] |
One Mobikwik Systems Limited has informed the Exchange about Newspaper Publication for the Notice of Postal Ballot, remote e-voting information and Form PAS-1 (Public Notice) |
|
Modis Navnirman Limited
Modis Navnirman Limited [03-Jun-2026] |
Modis Navnirman Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "Press Release Disclosure under Regulation 30 of SEBI (Listing Obligations and DisclosureRequirements) Regulations, 2015". |
|
Mtar Technologies Limited
Mtar Technologies Limited [03-Jun-2026] |
Kavitha Reddy Gangapatnam has Submitted to the Exchange a copy of Disclosure under Regulation 31(1) and 31(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
|
Muthoot Capital Services Limited
Muthoot Capital Services Limited [03-Jun-2026] |
Muthoot Capital Services Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
|
Nahar Industrial Enterprises Limite
Nahar Industrial Enterprises Limite [03-Jun-2026] |
Nahar Industrial Enterprises Limited has informed the Exchange about Credit Rating |
|
Natco Pharma Limited
Natco Pharma Limited [03-Jun-2026] |
Natco Pharma Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "NATCO Pharma Limited and Lupin Limited receive approval from U.S. FDA for Eribulin Mesylate Injection". |
Old Backoffice
Data available till FY 2024-25 (Historical)
New Backoffice
Data From FY 2025-26 onwards (Latest)
